Gen-Probe Inc. (GPRO: Quote) Tuesday said the US Food and Drug Administration has cleared its PANTHER system, a fully automated and integrated molecular testing platform designed with the flexibility to handle a wide range of testing needs.
The PANTHER system can initially be used to test for the common sexually transmitted infections Chlamydia trachomatis and Neisseria gonorrhoeae with the APTIMA Combo 2 assay.
According to the company, using this system, a single operator can process 275 samples in eight hours.
Gen-Probe will begin shipments of PANTHER systems to US customers during the second quarter.
Click here to receive FREE breaking news email alerts for GoPro Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org